Cost-Minimization Analysis of Baofukang Compared with Langyi in the Treatment of Pregnancy with Vulvovaginal Candidiasis / 中国药学杂志
Chinese Pharmaceutical Journal
;
(24): 1183-1187, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-858664
ABSTRACT
OBJECTIVE:
To conduct an economic evaluation of Baofukang versus Langyi in the treatment of pregnancy with vulvovaginal candidiasis by means of cost-minimization analysis. Furthermore, provide reference for reasonable clinical prescription and decision-making.METHODS:
Meta-analysis was conducted to support the safety data and effectiveness data of pharmacoeconomic evaluation based on literature review; guidelines and clinical experts' suggestion were used to find out treatment routes to calculate total direct medical costs. Cost-minimization analysis was conducted from the societal perspective.RESULTS:
The total direct medical costs of group Baofukang was lower than group Langyi's. Sensitivity analysis indicated the results were robust.CONCLUSION:
In contrast with Langyi, Baofukang is a more economic therapy in the treatment of pregnancy with vulvovaginal candidiasis.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Guía de Práctica Clínica
/
Evaluación Económica en Salud
/
Estudio pronóstico
Idioma:
Chino
Revista:
Chinese Pharmaceutical Journal
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS